This week the Assembly passed A4012/S2436 legislation which would authorize pharmacists to administer COVID19 testing. The Senate passed an identical version earlier this year. The bill has been sent to Governor Phil Murphy (D) for his signature and passage into law.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
This week, New Jersey joined Connecticut, Delaware, Massachusetts, New York, Pennsylvania, and Rhode Island in a regional pact to coordinate the regional reopening of the economy as the COVID-19 pandemic reaches its apex in the region. The Pact shall include state officials, economic experts and public health officials. No timeline or details are available, but the vision is a gradual return to work in the region.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
NACDS submitted comments to the Board of Pharmacy urging regulators to reconsider plans to require compliance with USP Ch. <800> by July 1, 2018, ahead of the USP’s December 1, 2019 effective date. At its December meeting, the Board heeded the concerns raised by NACDS and others in the pharmacy community about early implementation and opted to delay compliance until December 2019.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.